• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Rare Diseases

    FDA Clears Mesoblast IND for Ryoncil in DMD Dystrophy

    GLOBENEWSWIRE

    Ryoncil® Revenues Increase 66% In Second Quarter Post Launch

    GLOBENEWSWIRE

    Ryoncil Launch Success Highlighted at Global Health Conferences

    GLOBENEWSWIRE

    Mesoblast Wins First FDA Nod and Launches Ryoncil Successfully

    GLOBENEWSWIRE

    FDA Provides Seven Years of Orphan-Drug Approval for Ryoncil

    GLOBENEWSWIRE

    Mesoblast Files for Pediatric Rare Disease Designations for Rexlemestrocel-L

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.